CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD
Authors
Keywords
-
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 119, Issue 7, Pages 861-875
Publisher
Springer Nature
Online
2012-06-21
DOI
10.1007/s00702-012-0820-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts
- (2017) Julie A. Schneider et al. JOURNAL OF ALZHEIMERS DISEASE
- Specific Neuromodulatory Actions of Amyloid-β on Dopamine Release in Rat Nucleus Accumbens and Caudate Putamen
- (2017) Elisa Mura et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
- (2017) Fransje E. Reesink et al. JOURNAL OF ALZHEIMERS DISEASE
- Correlation between Cognitive Impairment and CSF Biomarkers in Amnesic MCI, non-Amnesic MCI, and Alzheimer's Disease
- (2017) Andreas Haldenwanger et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
- (2012) M. Wagner et al. NEUROLOGY
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Cerebral amyloid angiopathy in the elderly
- (2011) Anand Viswanathan et al. ANNALS OF NEUROLOGY
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease
- (2011) Glenda M. Halliday et al. JOURNAL OF NEURAL TRANSMISSION
- Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study)
- (2011) W. G. J. Reid et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cerebrospinal fluid amyloid and tau in LRRK2 mutation carriers
- (2011) J. O. Aasly et al. NEUROLOGY
- Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
- (2011) N. S. M. Schoonenboom et al. NEUROLOGY
- Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism
- (2011) S. Pappata et al. NEUROLOGY
- Predicting MCI outcome with clinically available MRI and CSF biomarkers
- (2011) D. Heister et al. NEUROLOGY
- Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
- (2010) Lon S. Schneider et al. Alzheimers & Dementia
- Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation
- (2010) Eri Himeno et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- Longitudinal Changes in White Matter Disease and Cognition in the First Year of the Alzheimer Disease Neuroimaging Initiative
- (2010) Owen Carmichael ARCHIVES OF NEUROLOGY
- The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimers Disease from Non-Alzheimers Dementia
- (2010) P.E. Spies et al. Current Alzheimer Research
- Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic
- (2010) Maartje I. Kester et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- PET imaging of brain amyloid in dementia: a review
- (2010) Harriet Quigley et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
- (2010) M. Andersson et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- CSF markers of neurodegeneration in Parkinson’s disease
- (2010) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies
- (2010) E. Mulugeta et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Differential levels of -synuclein, -amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- (2010) K. Kasuga et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography
- (2010) David J. Brooks MOVEMENT DISORDERS
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
- (2010) M.E. Kalaitzakis et al. NEUROBIOLOGY OF DISEASE
- Comparing predictors of conversion and decline in mild cognitive impairment
- (2010) S. M. Landau et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Specific inhibitory effect of amyloid-β on presynaptic muscarinic receptor subtypes modulating neurotransmitter release in the rat nucleus accumbens
- (2010) M. Grilli et al. NEUROSCIENCE
- Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease
- (2010) James B. Leverenz et al. PARKINSONISM & RELATED DISORDERS
- The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
- (2009) Caroline H. Williams-Gray et al. BRAIN
- Rapid Progression from Mild Cognitive Impairment to Alzheimer’s Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the APOE ε4/ε4 Genotype
- (2009) Elin S. Blom et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics
- (2009) Walter Maetzler et al. NEUROBIOLOGY OF DISEASE
- MRI and CSF biomarkers in normal, MCI, and AD subjects: Diagnostic discrimination and cognitive correlations
- (2009) P. Vemuri et al. NEUROLOGY
- CSF biomarkers in relationship to cognitive profiles in Alzheimer disease
- (2009) A. E. van der Vlies et al. NEUROLOGY
- Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients
- (2009) Alessandro Martorana et al. NEUROPSYCHOPHARMACOLOGY
- Dopaminergic function and progression of Parkinson's disease: PET findings
- (2009) G. Biju et al. PARKINSONISM & RELATED DISORDERS
- Plasma β-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype
- (2009) Meritxell Gomis et al. STROKE
- Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- (2008) Lucilla Parnetti et al. BIOLOGICAL PSYCHIATRY
- Early Discriminatory Diagnosis of Dementia with Lewy Bodies
- (2008) Dag Aarsland et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- CSF levels of β-amyloid 1-42, tau and phosphorylated tau protein in CADASIL
- (2008) P. Formichi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease
- (2008) Dietmar Rudolf Thal et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- l-dopa modulates motor cortex excitability in Alzheimer’s disease patients
- (2008) Alessandro Martorana et al. JOURNAL OF NEURAL TRANSMISSION
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
- Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease
- (2008) Gianluigi Lunardi et al. PARKINSONISM & RELATED DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now